MIST Therapy® is a painless, noncontact, low-frequency ultrasound delivered through a fluid (e.g., saline) mist to the wound bed. Unlike most wound therapies that are limited to treating the wound surface, the energy continues to travel below the wound surface.

The result of these gentle sound waves pushing against the tissue include:

Removal of Barriers

  • Reducing and removing a wide range of bacteria (1, 2)

Promoting of Healing

  • Increasing perfusion through vasodilation (3)
  • Increasing oxygen and nutrients to the tissue (4)

REFERENCES

  1. Serena T, et al. The Impact of Noncontact, Nonthermal,Low-Frequency Ultrasound on Bacterial Counts in Experimental and Chronic Wounds. Ostomy Wound Management 2009;55(1):22-30.
  2. Kavros SJ, Schenck EC. Use of Noncontact Low-Frequency Ultrasound in the Treatment of Chronic Foot and Leg Ulcerations: A 51 Patient Analysis. JAPMA 2007;97(2):95-101.
  3. Ennis WJ, Valdes W, Gainer M, Meneses P. Evaluation of Clinical Effectiveness of MIST Ultrasound Therapy for the Healing of Chronic Wounds. Adv Skin Wound Care 2006;20 #4.
  4. Kavros SJ, Miller, J. Hanna, S. Treatment of Ischemic Wounds with non-contact Low Frequency Ultrasound- The Mayo Clinic Experience 2004-2006., Adv Skin Wound Care 2007;19:437-46

INTELLECTUAL PROPERTY

Notice is hereby provided by way of this Virtual Patent Mark per 35 U.S.C. § 287(a) that the Celleration Inc. products or portions thereof listed below are covered under one or more patents in the United States or elsewhere. Additional patents may be pending in the United States or elsewhere.

Last updated: July 20, 2015

Wound Care

MIST Therapy® System, UltraMIST System, MIST Therapy® Applicator, MIST 360° Applicator, and UltraMIST Applicator

In the United States:

MIST® Systems (includes MIST Therapy® System and UltraMIST System), methods and devices or portions thereof are protected by one or more of the following United States Patents: 6,478,754; 6,533,803; 6,569,099; 6,601,581; 6,663,554; 6,761,729; 6,960,173; 7,914,470; 8,235,919; D733,319; D733,321
MIST Therapy Applicator, MIST 360° Applicator and UltraMIST Applicator or portions thereof are protected by one or more of the following United States Patents: 6,964,647; 7,713,218; 7,785,277; D733,319; D733,321

In Countries other than the United States:

Patents marked as “EPXXXXXX” denote a European Patent number. Inclusion of this number in a specific country list provides that the EP patent post grant is validated in that country.

In France:

MIST Systems, methods and devices or portions thereof are protected by one or more of the following French Patents: EP1355696; EP1322275

In Germany:

MIST Systems, methods and devices or portions thereof are protected by one or more of the following German Patents: EP1355696; EP1322275

In United Kingdom:

MIST Systems, methods and devices or portions thereof are protected by one or more of the following United Kingdom Patents: EP1355696; EP1322275

In Canada:

MIST Systems, methods and devices or portions thereof are protected by one or more of the following Canadian Patents: CA2463600; CA2521117

In China:

MIST Systems, methods and devices or portions thereof are protected by one or more of the following Chinese Patents: CN1466445

In India:

MIST Systems, methods and devices or portions thereof are protected by one or more of the following Indian Patents: IN207058; IN228689

In Japan:

MIST Systems, methods and devices or portions thereof are protected by one or more of the following Japanese Patents: JP4164582

In Singapore:

MIST Systems, methods and devices or portions thereof are protected by one or more of the following Singapore Patents: SG95385